Skip to Main Content

Paper Details

A Phase Ib/IIa Study of the Pan-BET Inhibitor ZEN-3694 in Combination with Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer.
Clin Cancer Res
72
2020
Author NameAffiliation
Rahul AggarwalUniversity of California san francisco
David M Nanus
Elisabeth I HeathKarmanos Cancer Institute, Wayne State University
Felix Y FengUniversity of California san francisco
Eric J SmallUniversity of California san francisco
Wassim AbidaMemorial Sloan Kettering Cancer Center
Joshi J AlumkalOregon Health & Science University
Joshi J AlumkalUniversity of Michigan Rogel Cancer Center ann arbor
  • 1 - 8

Datasets

Release 1.2